Steven Freedman
Neurology · Raleigh, NCNPI 1609891613
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Sanofi at 34.1% of the total. Reporting peaked in 2019 at $40,262 and has fallen 99.8% since, to $64 in 2024. Among neurology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 308 payments — averaging $137.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$14K
- Biogen$10K
- AstraZeneca$5K
- Mallinckrodt Enterprises LLC$4K
- Teva Pharmaceuticals USA, Inc.$4K
- Genentech USA, Inc.$3K
- plus $2K from 15 others
Across 45 payments — averaging $3468.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$95K
- Roche Products Limited$27K
- Alkermes, Inc.$22K
- Biogen$12K
What the payments were for
- Consulting fees$11,85028%
- Speaking & faculty fees$20,54749%
- Travel & lodging$5,57213%
- Food & beverage$4,24610%
- Education$850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 27 | $14,442 |
| Biogen | 36 | $9,534 |
| AstraZeneca | 13 | $4,807 |
| Mallinckrodt Enterprises LLC | 10 | $4,126 |
| Teva Pharmaceuticals USA, Inc. | 25 | $3,627 |
| Genentech USA, Inc. | 40 | $3,447 |
| Novartis | 32 | $1,097 |
| EMD Serono, Inc. | 22 | $343 |
| Supernus Pharmaceuticals, Inc. | 67 | $227 |
| Amgen | 8 | $184 |
| AbbVie(2 entities) | 10 | $146 |
| Sanofi-aventis U.S. LLC | 1 | $78 |
| CSL Behring | 4 | $56 |
| Lilly USA, LLC | 4 | $50 |
| Assertio Therapeutics, Inc. | 2 | $24 |
| Tanabe Pharma America, Inc. | 1 | $24 |
| Acorda Therapeutics, Inc | 2 | $23 |
| Boston Scientific | 1 | $21 |
| Bristol Myers Squibb | 1 | $19 |
| UCB, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$42,299 in reported general payments places this provider in the 90th percentile of 566 neurology providers in North Carolina.
Other neurology in Raleigh
- John ScagnelliRaleigh$429K
- Timothy RyanRaleigh$85K
- Casey JeffreysRaleigh$82K
- Sommer PhilipsRaleigh$46K
- Jill ConwayCharlotte$1M
- Matthew CarraroCharlotte$695K
- Richard SaterGreensboro$682K
- Sara SaccoMatthews$651K
- Megan DonnellyCharlotte$601K
- Kevin KahnDurham$587K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.